Tag: Keytruda

Personalized cancer vaccine: Moderna news leads to market frenzy

Moderna stock just surged 90% after its experimental vaccine for deadliest skin cancer passed a landmark late-stage trial. The mRNA-Keytruda ...

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

Tag: Keytruda

Personalized cancer vaccine: Moderna news leads to market frenzy

Menu

About Us